Colon-specific drug delivery using ethylcellulose and chitosan in the coat of compression-coated tablets

References

• Chourasia MK, Jain SK. (2004). Polysaccharides for colon targeted drug delivery. Drug Deliv, 11:129–148.
   PubMed Web of Science ®Google Scholar
• Faber SM, Korelitz BI. (1993). Experience with Eudragit-S-coated mesalamine (Asacol) in inflammatory bowel disease. An open study. J Clin Gastroenterol, 17:213–218.
   PubMed Web of Science ®Google Scholar
• Hardy JG, Healey JN, Reynolds JR. (1987). Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease. Aliment Pharmacol Ther, 1:273–280.
   PubMedGoogle Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. (1987). Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med, 317:1625–1629.
   PubMed Web of Science ®Google Scholar
• Rubinstein A. (1995). Approaches and opportunities in colon-specific drug delivery. Crit Rev Ther Drug Carrier Syst, 12:101–149.
   PubMed Web of Science ®Google Scholar
• Gwinup G, Elias AN, Domurat ES. (1991). Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules. Gen Pharmacol, 22: 243–246.
   PubMedGoogle Scholar
• Hovgaard L, Brondsted H. (1996). Current applications of polysaccharides in colon targeting. Crit Rev Ther Drug Carrier Syst, 13:185–223.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Mittal BR, Kumria R. (2005). In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int J Pharm, 289:79–85.
   PubMed Web of Science ®Google Scholar
• Tomlin J, Read N. (1988). The relation between bacterial degradation of viscous polysaccharides and stool output in human beings. British Journal of Nutrition, 60:467–475.
   PubMed Web of Science ®Google Scholar
• Turkoglu M, Ugurlu T. (2002). In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur J Pharm Biopharm, 53:65–73.
   PubMed Web of Science ®Google Scholar
• Ugurlu T, Turkoglu M, Gurer U, Akarsu B. (2007). Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture. Eur J Pharm Biopharm, 67:202–210.
   PubMed Web of Science ®Google Scholar
• Wakerly Z, Fell JT, Attwood D, Parkins D. (1996). Pectin/ethylcellulose film coating formulations for colonic drug delivery. Pharm Res, 13:1210–1212.
   PubMed Web of Science ®Google Scholar
• Rubinstein A, Radai R. (1995). In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. Eur J Pharm Biopharm, 41:291–295.
   Web of Science ®Google Scholar
• Krishnaiah YS, Satyanarayana S, Prasad YV. (1999). Studies of guar gum compression-coated 5-aminosalicylic acid tablets for colon-specific drug delivery. Drug Dev Ind Pharm, 25:651–657.
   PubMed Web of Science ®Google Scholar
• Krishnaiah Y, Satyanarayana S, Rama Prasad Y, Narasimha Rao S. (1998). Evaluation of guar gum as a compression coat for drug targeting to colon. Int J Pharm, 171:137–146.
   Web of Science ®Google Scholar
• Lin KH, Lin SY, Li MJ. (2001). Compression forces and amount of outer coating layer affecting the time-controlled disintegration of the compression-coated tablets prepared by direct compression with micronized ethylcellulose. J Pharm Sci, 90:2005–2009.
   PubMed Web of Science ®Google Scholar
• Lin SY, Lin KH, Li MJ. (2002). Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets. J Pharm Sci, 91:2040–2046.
   PubMed Web of Science ®Google Scholar
• Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki T, Yamamoto A, Muranishi S. (1997). Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J Pharm Sci, 86:1016–1021.
   PubMed Web of Science ®Google Scholar
• Zhang H, Neau SH. (2002). In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents. Biomaterials, 23:2761–2766.
   PubMed Web of Science ®Google Scholar
• Zhang H, Alsarra IA, Neau SH. (2002). A chitosan-containing multiparticulate system for macromolecule delivery to the colon. Int J Pharm, 239:197–205.
   PubMed Web of Science ®Google Scholar
• Liu H, Yang, XG, Nie SF, Wei LL, Zhou LL, Liu H, Tang R, Pan WS. (2007). Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation. Int J Pharm, 332:115–124.
   PubMed Web of Science ®Google Scholar
• Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. (1988). Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 29, 1035–1041.
   PubMed Web of Science ®Google Scholar
• Simon GL, Gorbach SL. (1986). The human intestinal microflora. Dig Dis Sci, 31:S147–162S
   PubMed Web of Science ®Google Scholar
• Press A, Hauptmann I, Hauptmann L, Fuchs B, Fuchs M, Ewe K, Ramadori G. (1998). Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment Pharm Ther, 12:673–678.
   PubMed Web of Science ®Google Scholar
• Boot RG, Bussink AP, Verhoek M, de Boer PA, Moorman AF, Aerts JM. (2005). Marked differences in tissue-specific expression of chitinases in mouse and man. J Histochem Cytochem, 53:1283–1292.
   PubMed Web of Science ®Google Scholar
• Paoletti MG, Norberto L, Damini R, Musumeci S. (2007). Human gastric juice contains chitinase that can degrade chitin. Ann Nutr Metab, 51:244–251.
   PubMed Web of Science ®Google Scholar
• Boot RG, Blommaart EF, Swart E, Ghauharali-van der Vlugt K, Bijl N, Moe C, Place A, Aerts JM. (2001). Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem, 276:6770–6778.
   PubMed Web of Science ®Google Scholar
• Appel L, Zentner G. (1991). Use of modified ethylcellulose lattices for microporous coating of osmotic tablets. Pharm Res, 8:600–604.
   PubMed Web of Science ®Google Scholar
• Lin S, Li M, Lin K. (2004). Hydrophilic excipients modulate the time lag of time-controlled disintegrating press-coated tablets. AAPS PharmSciTech, 5:25–29.
   Web of Science ®Google Scholar
• Domard A. (1987). Determination of N-acetyl content in chitosan samples by cd measurements. Int J Biol Macromol, 9:333–336.
   Web of Science ®Google Scholar
• Chen R, Hwa H. (1996). Effect of molecular weight of chitosan with the same degree of deacetylation on the thermal, mechanical, and permeability properties of the prepared membrane. Carbohydr Polym, 29:353–358.
   Web of Science ®Google Scholar
• USP23/NF18. 1995. The United States Pharmacopeial Convention, Inc., Rockville, MD.
   Google Scholar
• Hawksworth G, Drasar BS, Hill MJ. (1971). Intestinal bacteria and the hydrolysis of glycosidic bonds. J Med Microbiol, 4:451–459.
   PubMed Web of Science ®Google Scholar
• Prizont R, Konigsberg N. (1981). Identification of bacterial glycosidases in rat cecal contents. Dig Dis Sci, 26:773–777.
   PubMed Web of Science ®Google Scholar